ABSTRACT
This chapter focuses on sustainable growth and competitive advantage. The range of opportunities is extremely broad, varying from product ideas to marketed products and from novel drug targets to complex devices and technologies to enhance the practice of medicine. The WTO and TRIPS initiatives are beginning to ensure greater attention to the need for high-quality clinical work and solid intellectual property (IP) protection. In mergers and acquisitions the package form Evaluate provides an updated database describing transactions, company profiles and valuations derived from bank equity analysis. Web-based searching permits detailed searching starting with only a hazy idea of the object of the search. The process of due diligence in and through the search phase is an intrinsic part of the evaluation of opportunities and shows that the value of an experienced hand in guiding the criteria for the search and evaluation process is of paramount importance.
